Clinical Trials Browser

Phase 1 × Prostatic Neoplasms × siltuximab × Clear all

NCT00401765 2014-05-26

A Study of CNTO 328 in Patients With Metastatic Hormone-Refractory Prostate Cancer

Phase 1 Completed

Prostatic Neoplasms